News coverage about Intuitive Surgical (NASDAQ:ISRG) has trended somewhat positive on Sunday, according to Accern Sentiment Analysis. The research group identifies negative and positive press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Intuitive Surgical earned a media sentiment score of 0.22 on Accern’s scale. Accern also gave news stories about the medical equipment provider an impact score of 46.4937940078001 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Several brokerages have recently issued reports on ISRG. BidaskClub raised shares of Intuitive Surgical from a “buy” rating to a “strong-buy” rating in a report on Thursday, January 11th. Barclays reissued an “overweight” rating and issued a $465.00 price target on shares of Intuitive Surgical in a report on Thursday, January 11th. Citigroup reduced their target price on shares of Intuitive Surgical to $507.00 and set a “buy” rating for the company in a research note on Tuesday, February 6th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $490.00 target price on shares of Intuitive Surgical in a research note on Friday, January 26th. Finally, Vetr raised shares of Intuitive Surgical from a “buy” rating to a “strong-buy” rating and set a $443.17 target price for the company in a research note on Thursday, February 8th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company. Intuitive Surgical currently has a consensus rating of “Buy” and an average price target of $408.76.
Shares of ISRG stock traded down $6.09 during midday trading on Friday, reaching $435.86. 863,309 shares of the company were exchanged, compared to its average volume of 593,420. Intuitive Surgical has a 12-month low of $247.50 and a 12-month high of $452.00. The firm has a market cap of $49,279.20, a price-to-earnings ratio of 76.74, a PEG ratio of 5.19 and a beta of 0.51.
In other Intuitive Surgical news, CFO Marshall Mohr sold 7,500 shares of the business’s stock in a transaction dated Monday, February 5th. The shares were sold at an average price of $414.19, for a total transaction of $3,106,425.00. Following the sale, the chief financial officer now directly owns 13,816 shares of the company’s stock, valued at approximately $5,722,449.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Curet Myriam sold 262 shares of the business’s stock in a transaction dated Tuesday, January 30th. The stock was sold at an average price of $431.50, for a total transaction of $113,053.00. Following the sale, the executive vice president now directly owns 2,152 shares in the company, valued at $928,588. The disclosure for this sale can be found here. Insiders have sold a total of 102,770 shares of company stock worth $43,410,836 over the last three months. Insiders own 2.20% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.